DJIA 16,051.19 36.81 0.23%
NASDAQ 4,343.98 75.22 1.76%
S&P 500 1,868.00 15.79 0.85%
market minute promo

AMYRIS INC COM (NASDAQ: AMRS)

1.44 0.03 (2.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMRS $1.44 2.13%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.35
Previous Close $1.41
Daily Range $1.35 - $1.45
52-Week Range $1.13 - $3.11
Market Cap $276.7M
P/E Ratio -0.82
Dividend (Yield) $0.00 (0.0%)
Volume 50,239
Average Daily Volume 145,563
Current FY EPS -$1.13

Sector

Healthcare

Industry

Drug Makers

AMYRIS INC COM (AMRS) Description

Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Website: http://www.amyris.com/

News & Commentary Rss Feed

These Stocks Could Double in 2016

Investing in stocks that have the potential for 100% gains often means taking high-risk bets, but the conditions may be right for Seadrill, Garmin, and Amyris in 2016. Here's why.

Stocks Hitting 52-Week Lows

Amyris Signs Multi-Million-Dollar BiofeneĀ® Ingredient Supply Agreement for Global Nutraceuticals and

Amyris Signs Multi-Million-Dollar BiofeneĀ® Ingredient Supply Agreement for Global Nutraceuticals and Vitamins Market, May Yield ~$20M Annual Revs

Can Bio-Engineered Products Make a Turnaround in 2016?

Amyris and Solazyme have a lot of potential for growth, but investors need to be cautious jumping in before both prove their ability to make money.

Why Amyris (AMRS) Could Be Positioned for a Slump

15 Fresh Analyst Stock Picks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney a

Top Analyst Upgrades and Downgrades: AbbVie, Apple, Autodesk, JD.com, CyberArk, Dean Foods, Disney and More

Amyris' (AMRS) CEO John Melo on Q3 2015 Results - Earnings Call Transcript

Solazyme Inc: Shifting Partnerships Show Improved Focus

Cutting a major production partner could be just what Solazyme Inc needs to keep its business focused.

Amyris Expands Distribution of Muck Daddy

See More AMRS News...

AMRS's Top Competitors

AMRS $1.44 (2.13%)
Current stock: AMRS
FCEL $4.87 (1.25%)
Current stock: FCEL
CDXS $3.90 (-1.27%)
Current stock: CDXS
RTK $1.70 (-2.86%)
Current stock: RTK